Benitec Biopharma target price raised to $17 from $14 by Raymond James
BNTC•Raymond James raised its target price for Benitec Biopharma to $17 from $14.
Related News
Japan bonds steady ahead of BOJ decision; strong auction lends support
TLT•
Doosan Enerbility signs contract with NuScale Power
SMR•
GE Healthcare: RBC raises target price to $90 from $80
GEHC•
Boston Scientific Corporation: Needham cuts target price to $48 from $57
BSX•
Chipotle Mexican Grill: Jefferies cuts target price to $32 from $36
CMG•